Vaccination with fixed feline immunodeficiency virus (FIV) infected cells: protection, breakthrough and specificity of response (Q45765788)

15 December 2017

title

Vaccination with fixed feline immunodeficiency virus (FIV) infected cells: protection, breakthrough and specificity of response (English)

1 reference

15 December 2017

feline immunodeficiency virus

main subject

object named as

feline immunodeficiency virus

1 reference

Bishop SA

1

1 reference

15 December 2017

Stokes CR

2

1 reference

15 December 2017

Gruffydd-Jones TJ

3

1 reference

15 December 2017

Whiting CV

4

1 reference

15 December 2017

Humphries JE

5

1 reference

15 December 2017

Osborne R

6

1 reference

15 December 2017

Papanastasopoulou M

7

1 reference

15 December 2017

Harbour DA

8

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 September 1996

1 reference

15 December 2017

published in

Vaccine

1 reference

15 December 2017

volume

14

1 reference

15 December 2017

issue

13

1 reference

15 December 2017

page(s)

1243-1250

1 reference

15 December 2017

Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900023-0

7 January 2021

Impaired T-cell priming and proliferation in cats infected with feline immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900023-0

7 January 2021

An early defect in primary and secondary T cell responses in asymptomatic cats during acute feline immunodeficiency virus (FIV) infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900023-0

7 January 2021

Programmed cell death (apoptosis) as a mechanism of cell death in peripheral blood mononuclear cells from cats infected with feline immunodeficiency virus (FIV).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900023-0

7 January 2021

The development of a vaccine against feline immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900023-0

7 January 2021

Enhancement after feline immunodeficiency virus vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900023-0

7 January 2021

Experimental vaccine protection against feline immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900023-0

7 January 2021

Experimental vaccine protection against homologous and heterologous strains of feline immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900023-0

7 January 2021

Anti-cell antibody in macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900023-0

7 January 2021

Protection in simian immunodeficiency virus-vaccinated monkeys correlates with anti-HLA class I antibody response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900023-0

7 January 2021

Development of IL-2 Independent Feline Lymphoid Cell Lines Chronically Infected with Feline Immunodeficiency Virus: Importance for Diagnostic Reagents and Vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900023-0

7 January 2021

An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900023-0

7 January 2021

Virus neutralization reveals antigenic variation among feline immunodeficiency virus isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900023-0

7 January 2021

Immunodiagnosis of feline immunodeficiency virus infection using recombinant viral p17 and p24

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900023-0

7 January 2021

A formalin-inactivated whole SIV vaccine confers protection in macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900023-0

7 January 2021

Evolution of structural proteins of feline immunodeficiency virus: molecular epidemiology and evidence of selection for change

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900023-0

7 January 2021

Specific and non-specific immunity and protection of macaques against SIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900023-0

7 January 2021

Preliminary report: protection of cynomolgus macaques against simian immunodeficiency virus by fixed infected-cell vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900023-0

7 January 2021

Detection of anti-human cell antibodies in sera from macaques immunized with whole inactivated virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900023-0

7 January 2021

MHC-antigens: constituents of the envelopes of human and simian immunodeficiency viruses.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900023-0

7 January 2021

Studies on the specificity of the vaccine effect elicited by inactivated simian immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2896%2900023-0

7 January 2021

10.1016/S0264-410X(96)00023-0

Identifiers

DOI

1 reference

15 December 2017

PubMed ID

8961513

1 reference

15 December 2017